142 related articles for article (PubMed ID: 3116710)
1. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
Porcellati S; Costantini V; Prosdocimi M; Pistolesi R; Porrovecchio P; Nenci GG; Goracci G
Thromb Res; 1987 Jul; 47(1):15-24. PubMed ID: 3116710
[TBL] [Abstract][Full Text] [Related]
2. The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
Porcellati S; Costantini V; Prosdocimi M; Stasi M; Pistolesi R; Nenci GG; Goracci G
Agents Actions; 1990 Mar; 29(3-4):364-73. PubMed ID: 2111085
[TBL] [Abstract][Full Text] [Related]
3. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.
Galli C; Agradi E; Petroni A; Socini A
Pharmacol Res Commun; 1980 Apr; 12(4):329-37. PubMed ID: 7393988
[No Abstract] [Full Text] [Related]
4. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
[TBL] [Abstract][Full Text] [Related]
5. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
Luzzatto G; Fabris F; Dal Bo Zanon R; Girolami A
Arzneimittelforschung; 1986 Jun; 36(6):972-3. PubMed ID: 2943294
[TBL] [Abstract][Full Text] [Related]
6. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Zanetti A; Zatta A; Prosdocimi M; Dejana E
Eur J Pharmacol; 1986 Aug; 128(1-2):119-27. PubMed ID: 2944757
[TBL] [Abstract][Full Text] [Related]
7. Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
Heinroth I; Förster W
Prostaglandins Leukot Med; 1984 Apr; 14(1):13-4. PubMed ID: 6427789
[No Abstract] [Full Text] [Related]
8. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
Hakim G; Fiorentini D; Falasca A; Prosdocimi M; Rossi CA
Experientia; 1988 Mar; 44(3):226-8. PubMed ID: 2832208
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release.
Needleman SW; Spector AA; Hoak JC
Prostaglandins; 1982 Nov; 24(5):607-22. PubMed ID: 6819602
[TBL] [Abstract][Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Prosdocimi M; Finesso M; Tessari F; Gorio A; Languino LR; de Gaetano G; Dejana E
Thromb Res; 1985 Aug; 39(4):399-409. PubMed ID: 3840290
[TBL] [Abstract][Full Text] [Related]
12. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
[TBL] [Abstract][Full Text] [Related]
13. Cloricromene inhibits G-protein-mediated activation of phospholipase A2 in human platelets.
Stasi M; Gresele P; Prosdocimi M; Porcellati S; Quero E; Pieretti G; Nenci GG; Goracci G
J Lipid Mediat; 1993 Jul; 7(3):253-67. PubMed ID: 8219005
[TBL] [Abstract][Full Text] [Related]
14. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
Socini A; Petroni A; Colli S; Colombo C; Galli C
Pharmacol Res Commun; 1982 Mar; 14(3):189-97. PubMed ID: 7048340
[No Abstract] [Full Text] [Related]
15. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
Stuart MJ; Dusse J; Clark DA; Walenga RW
Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
Sekiya K; Okuda H
Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
[TBL] [Abstract][Full Text] [Related]
17. Enhanced incorporation of exogenous arachidonic acid into phosphatidylinositol and other phospholipids during the early stages of thrombin-induced aggregation in gerbil platelets.
Agwu DE; Johnstone I; Crane S; Holub BJ
Lipids; 1983 Dec; 18(12):859-62. PubMed ID: 6420635
[TBL] [Abstract][Full Text] [Related]
18. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
19. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
20. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
